Mammoth Biosciences

Mammoth Biosciences is a biotech company that has developed the world’s first and only CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA. CRISPR pioneer Jennifer Doudna and Trevor Martin, Ashley Tehranchi, Janice Chen and Lucas Harrington co-founded the company. Mammoth is on a mission to leverage the power of CRISPR to democratize disease detection by bringing accurate and affordable testing out of the laboratory and into the point of care. The company has raised nearly $25 million in funding from investors including Mayfield, NFX, 8VC, AME Cloud, Wireframe, Kairos and Boom Capital.

Visit the Mammoth Biosciences website

1 articles from Mammoth Biosciences

Mammoth Biosciences contributors

About Us



Privacy Policy & Terms of Service

© 2022 World Economic Forum

Join the Forum